within Pharmacolibrary.Drugs.P_AntiparasiticProductsInsecticidesAndRepellents.P01B_Antimalarials.P01BX02_ArterolaneAndPiperaquine;

model ArterolaneAndPiperaquine
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_2C_enteral(
    weight = 70,
    F = 0.9,
    Cl = 6.944444444444445e-06,
    adminDuration = 600,
    adminMass = 150 / 1000000,
    adminCount = 1,
    Vd = 0.09,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    ka = 0.008333333333333333,
    Tlag = 18.0,
    Vdp = 0.075,
    k12 = 6.11111111111111e-06,
    k21 = 6.11111111111111e-06);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>ArterolaneAndPiperaquine</td></tr><tr><td>ATC code:</td><td>P01BX02</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>2</td></tr>
    <tr><td>dosage:</td><td>150</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>90</td><td>L</td></tr>
    <tr><td>clearance:</td><td>25</td><td>L/h</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Arterolane and piperaquine is a fixed-dose combination antimalarial drug used for the treatment of uncomplicated Plasmodium falciparum malaria. Arterolane is a synthetic ozonide antimalarial agent, while piperaquine is a bisquinoline antimalarial agent. This combination is approved and is in current clinical use, particularly in India and some other malaria-endemic regions.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers (Indian adults, both sexes), single oral dose of arterolane maleate 150 mg and piperaquine phosphate 750 mg, under fed conditions.</p><h4>References</h4><ol><li><p>Valecha, N, et al., &amp; Anvikar, AR (2016). Comparison of the safety and efficacy of fixed-dose combination of arterolane maleate and piperaquine phosphate with chloroquine in acute, uncomplicated Plasmodium vivax malaria: a phase III, multicentric, open-label study. <i>Malaria journal</i> 15 42–None. DOI:<a href=\"https://doi.org/10.1186/s12936-016-1084-1\">10.1186/s12936-016-1084-1</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/26818020/\">https://pubmed.ncbi.nlm.nih.gov/26818020</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.P.P01BX02 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end ArterolaneAndPiperaquine;
